RA Capital Management, LLC, 10% Owner at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), bought 6,200 shares at $20.00 ($126K) on 2008-12-23, disclosed to the SEC on 2008-12-31.
Open-market purchase of $126k BSTC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.75 | 350 | $7K | 5.2% |
| 2 | $19.50 | 650 | $13K | 10.1% |
| 3 | $19.90 | 170 | $3K | 2.7% |
| 4 | $19.93 | 200 | $4K | 3.2% |
| 5 | $19.95 | 1,950 | $39K | 31.0% |
| 6 | $21.00 | 2,180 |
| $46K |
| 36.4% |
| 7 | $20.00 | 500 | $10K | 8.0% |
| 8 | $22.00 | 200 | $4K | 3.5% |
| Total | $20.27 avg | 6,200 | $126K | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |